• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Retrospective study shows toric IOL rotation rate to be low at 2.1%

Video

Edward Hu, MD, PhD, looked at 812 toric IOLs utilized of various platforms, concluding a low total toric rotation rate at 2.1%.

“In my experience and my opinion, it is possible that the extended haptic contact surface area with the capsular bag for the toric enVista platform may contribute to its superior rotation stability.”

Edward Hu, MD, PhD, gave a presentation during the 2022 ASCRS annual meeting on his four year retrospective analysis of comparative evaluation of clinically significant IOL rotations in his personal experience.

Looking at the use of over 812 Toric IOLs of various platforms, he concluded that the total Toric rotation rate in his experience was low at 2.1%

“In my experience and my opinion, it is possible that the extended haptic contact surface area with the capsular bag for the toric enVista platform may contribute to its superior rotation stability.”

Related Videos
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.